PDT Partners, LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 187 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.

Quarter-by-quarter ownership
PDT Partners, LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,356,946
-24.7%
44,229
-1.6%
0.17%
-31.0%
Q2 2023$1,801,267
-1.8%
44,953
+0.0%
0.25%
-0.4%
Q1 2023$1,834,410
+156.9%
44,950
+252.7%
0.25%
+388.2%
Q3 2021$714,000
-8.3%
12,743
-0.8%
0.05%0.0%
Q2 2021$779,000
-78.7%
12,843
-81.6%
0.05%
-79.5%
Q2 2020$3,658,000
+4.4%
69,713
-33.3%
0.25%
-10.1%
Q1 2020$3,504,000
+11.0%
104,500
+49.9%
0.28%
+42.1%
Q4 2019$3,157,000
+19.0%
69,7000.0%0.20%
+23.4%
Q3 2019$2,653,000
-12.5%
69,7000.0%0.16%
-11.7%
Q2 2019$3,031,000
+14.2%
69,7000.0%0.18%
+19.3%
Q1 2019$2,653,000
-11.6%
69,700
-0.1%
0.15%
-10.7%
Q4 2018$3,001,000
-12.4%
69,760
+0.1%
0.17%
+18.3%
Q3 2018$3,426,000
+6.7%
69,706
-30.4%
0.14%
+16.4%
Q2 2018$3,211,000
+127.1%
100,200
+191.3%
0.12%
+281.2%
Q3 2015$1,414,000
-66.5%
34,396
-27.7%
0.03%
-69.5%
Q1 2015$4,224,000
+391.2%
47,544
+390.1%
0.10%
+23.5%
Q4 2014$860,000
+13.8%
9,700
+24.4%
0.08%
+325.0%
Q3 2014$756,000
+5.4%
7,8000.0%0.02%
+5.3%
Q2 2014$717,000
+29.7%
7,800
-1.3%
0.02%
+46.2%
Q1 2014$553,0007,9000.01%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
GAGNON SECURITIES LLC 563,415$21,753,4534.80%
Gagnon Advisors, LLC 180,331$6,962,5794.70%
Spyglass Capital Management LLC 868,686$33,539,9662.69%
Tamarack Advisers, LP 100,000$3,861,0001.99%
ARMISTICE CAPITAL, LLC 1,892,000$73,050,1201.27%
NEUMEIER POMA INVESTMENT COUNSEL LLC 276,590$10,679,1400.99%
RICE HALL JAMES & ASSOCIATES, LLC 437,285$16,883,5740.97%
Rock Springs Capital Management LP 1,032,600$39,868,6860.96%
OUTFITTER FINANCIAL LLC 25,860$998,4550.91%
Stephens Investment Management Group LLC 1,168,469$45,535,2370.82%
View complete list of PACIRA PHARMACEUTICALS INC shareholders